- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dyadic International Inc (DYAI)
Dyadic International Inc stock price live, this page displays NASDAQ DYAI stock exchange data. View the DYAI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Dyadic International Inc real time stock price chart below.
What Is the Dyadic International Inc Stock Price Today?
The Dyadic International Inc stock price today is 0.912.
What Is the Stock Symbol for Dyadic International Inc?
The stock symbol for Dyadic International Inc is "DYAI."
What Stock Exchange Does Dyadic International Inc Trade On?
Dyadic International Inc is listed and trades on the NASDAQ stock exchange.
Is Dyadic International Inc a Good Stock to Buy?
Determining whether Dyadic International Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DYAI quote. (ISIN: US26745T1016)
What Is the Dyadic International Inc Stock Price Today?
The Dyadic International Inc stock price today is 0.912.
What Is the Stock Symbol for Dyadic International Inc?
The stock symbol for Dyadic International Inc is "DYAI."
What Stock Exchange Does Dyadic International Inc Trade On?
Dyadic International Inc is listed and trades on the NASDAQ stock exchange.
Is Dyadic International Inc a Good Stock to Buy?
Determining whether Dyadic International Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DYAI quote. (ISIN: US26745T1016)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.900
0.948
52 wk Range
0.711
1.730
DYAI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.9000.948
52 wk Range
0.7111.730
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DYAI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
7.000
Upside
+667.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Dyadic International Inc Company Profile
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bioindustrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa’s Rubic One Health; joint development agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Dyadic International Inc Earnings Call Summary for Q3/2025
- Dyadic International (DYAI) reported Q3 2025 EPS of -$0.06, missing forecasts by 20%, with revenue of $1.165 million falling 22.67% below expectations, causing shares to drop 7.42% in after-hours trading.
- Revenue declined from $1.968 million year-over-year, primarily due to reduced license and milestone revenue, though grant revenue increased by $815,000. Cash position stands at $10.4 million as of September 30.
- The company completed its first commercial bulk protein product sale and rebranded as Dyadic Applied Biosolutions, signaling its transition 'from potential to execution' as a commercial organization.
- Management expects growth in product revenue within life sciences and food/nutrition markets, targeting bulk sales to distributors and manufacturers while expanding its product portfolio in cell culture media.
- CEO Mark Emalfarb highlighted efforts to 'mimic human breast milk' through product development, while the company raised $4.9 million through a public offering of 6,052,000 shares at $0.95 per share.
Last Updated: 2025-12-08, 08:12 a/m
Read Full TranscriptCompare DYAI to Peers and Sector
Metrics to compare | DYAI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDYAIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.5x | −1.7x | −0.6x | |
PEG Ratio | 1.48 | −0.04 | 0.00 | |
Price/Book | 12.7x | 2.4x | 2.6x | |
Price / LTM Sales | 9.9x | 157.7x | 3.4x | |
Upside (Analyst Target) | - | 47.5% | 40.5% | |
Fair Value Upside | Unlock | −2.2% | 4.4% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.000
(+667.54% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.06 / -0.05
Revenue / Forecast
1.16M / 1.50M
People Also Watch
FAQ
What Is the Dyadic (DYAI) Stock Price Today?
The Dyadic stock price today is 0.912
What Stock Exchange Does Dyadic Trade On?
Dyadic is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Dyadic?
The stock symbol for Dyadic is "DYAI."
What Is the Dyadic Market Cap?
As of today, Dyadic market cap is 33.00M.
What Is Dyadic's Earnings Per Share (TTM)?
The Dyadic EPS (TTM) is -0.22.
When Is the Next Dyadic Earnings Date?
Dyadic will release its next earnings report on Mar 31, 2026.
From a Technical Analysis Perspective, Is DYAI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Dyadic Stock Split?
Dyadic has split 0 times.
How Many Employees Does Dyadic Have?
Dyadic has 6 employees.
What is the current trading status of Dyadic (DYAI)?
As of Jan 23, 2026, Dyadic (DYAI) is trading at a price of 0.912, with a previous close of 0.912. The stock has fluctuated within a day range of 0.900 to 0.948, while its 52-week range spans from 0.711 to 1.730.
What Is Dyadic (DYAI) Price Target According to Analysts?
The average 12-month price target for Dyadic is USD7.000, with a high estimate of USD9 and a low estimate of USD5. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +667.54% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.